[Intracranial Meningiomas: I. Epidemiology, Aetiology, Pathogenesis and Prognostic Factors]
Overview
Affiliations
Introduction: Meningiomas are the most frequent group of intracranial tumours, accounting for around a third of all primary brain tumours. In most cases, they are benign neoplasms that start in the cells of the arachnoid mater and may be located in the intracranial and spinal cavities.
Aim: To perform a review of the information available on intracranial meningiomas that allows us to update current know-ledge on the subject.
Development: The review of the literature covers different aspects of intracranial meningiomas, including their epidemiology, histology, risk factors, neurogenetics, diagnostic techniques and prognostic factors.
Conclusions: Intracranial meningiomas are, today, the leading group of intracranial tumours. Although most of them are histologically benign, recurrence rates range between 10% and 20%, even after performing complete resections. Knowledge of risk factors and the genetic disorders that they present will make it easier in the future to introduce customised treatments to fit each case.
Imaging characteristics and surgical treatment of invasive meningioma.
Hou W, Ma Y, Xing H, Yin Y Oncol Lett. 2017; 13(5):2965-2970.
PMID: 28521402 PMC: 5431211. DOI: 10.3892/ol.2017.5833.
Genetic variants and increased risk of meningioma: an updated meta-analysis.
Han X, Wang W, Wang L, Wang X, Li G Onco Targets Ther. 2017; 10:1875-1888.
PMID: 28405167 PMC: 5378443. DOI: 10.2147/OTT.S130147.
Is "en-bloc" excision, an option for select large vascular meningiomas?.
Dhandapani S, Sharma K Surg Neurol Int. 2013; 4:102.
PMID: 24032077 PMC: 3766328. DOI: 10.4103/2152-7806.116307.
Ibebuike K, Ouma J, Gopal R Afr Health Sci. 2013; 13(1):118-21.
PMID: 23658577 PMC: 3645104. DOI: 10.4314/ahs.v13i1.16.